Press Release

Kyle Chiang, Ph.D.

Kyle Chiang has more than 10 years of rare disease drug development experience as a key member of discovery and clinical science teams. Most recently, he served as program executive of ATYR1940 at aTyr Pharma, where he led the program through early clinical development for patients with facioscapulohumeral muscular dystrophy. Kyle received his Ph.D. in macromolecular cellular structure and chemistry from the Scripps Research Institute.